Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a ‘new form of the disease’
Abstract
Deep brain stimulation (DBS) has been regarded as an efficient and safe treatment for Parkinson’s disease (PD) since being approved by the Food and Drug Administration (FDA) in 1997. It is estimated that more than 150 000 patients have been implanted, with a forecasted rapid increase in uptake with population ageing. Recent longitudinal follow-up studies have reported a significant increase in postoperative survival rates of patients with PD...
Paper Details
Title
Incoming ethical issues for deep brain stimulation: when long-term treatment leads to a ‘new form of the disease’
Published Date
May 14, 2020
Journal
Volume
47
Issue
1
Pages
20 - 25
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History